Reason for request
Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals in the extension of indication “relief of broncho-obstructive symptoms in patients with chronic obstructive pulmonary disease”.
Clinical Benefit
| Substantial |
Le service médical rendu par ATIMOS 12 microgrammes/dose, solution pour inhalation en flacon pressurisé est important.
|
Clinical Added Value
| no clinical added value |
ATIMOS 12 microgrammes/dose, solution pour inhalation en flacon pressurisé n'apporte pas d'amélioration du service médical rendu (ASMR V) par rapport aux autres bronchodilatateurs de longue durée d'action disponibles dans cette indication.
|
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
y1ndu0jvsmmkhQX5
